Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EURO SHOCK Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

NCT03813134 is registered in ClinicalTrials.gov with University of Leicester as lead sponsor.

NCT NCT03813134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EURO SHOCK Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock
Lead sponsor
University of Leicester
Phase
Not applicable
Overall status
Unknown status
Start date
October 11, 2019
Completion date
February 1, 2024
Enrollment
428 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock